Literature DB >> 21228434

Better use of primary care laboratory services following interventions to 'market' clinical guidelines in New Zealand: a controlled before-and-after study.

Andrew Tomlin1, Susan Dovey, Robin Gauld, Murray Tilyard.   

Abstract

CONTEXT: Laboratory tests for inflammatory response, thyroid function and infectious diarrhoea were not being ordered as recommended by clinical guidelines.
OBJECTIVE: To measure changes in community laboratory-test ordering following marketing programmes promoting guidelines recommendations.
DESIGN: Controlled before-and-after study involving 2 years of national laboratory payment data before and after each intervention. Comparisons were with doctors ordering the same tests but not receiving interventions.
SETTING: New Zealand primary care. PARTICIPANTS: 3161, 3140 and 3335 general practitioners and 2424, 2443 and 2766 Comparison doctors ordering inflammatory response, thyroid function and acute diarrhoea tests from community laboratories, July 2003 to March 2009.
INTERVENTIONS: Three separate marketing programmes to general practitioners, each comprising written material advising of guidelines recommendations, individual laboratory-test use feedback and professional development opportunities. MAIN OUTCOME MEASURES: Number of tests, tests/doctor, patients having tests and tested patients/doctor/year before and after each intervention. Change in expenditure from before each intervention to after.
RESULTS: For Intervention doctors, erythrocyte sedimentation rate tests decreased 60.0% after the intervention; tests for C-reactive protein increased 63.1%; simultaneous erythrocyte sedimentation rate and C-reactive protein orders decreased 32.6%. Tests for free thyroxine and free triiodothyronine decreased 44.1% and 36.0%. The proportion of thyroid function tests where thyroid-stimulating hormone was the sole test ordered increased from 43.2% before the intervention to 65.2% afterwards (p<0.001; 95% CI 21.7% to 22.2%). Testing for faecal culture decreased 31.5%, giardia and cryptosporidium 31.5%, and ova and parasites 56.9%. Faecal culture as the sole initial test increased from 31.4% to 39.1% (p<0.001; 95% CI 7.2% to 8.2%). Testing by Comparison doctors changed in the same direction but with significantly less magnitude. The estimated reduction in expenditure for study tests was 23.5%.
CONCLUSIONS: Clear information marketed to general practitioners improved the quality of laboratory test ordering for patients in New Zealand.

Entities:  

Mesh:

Year:  2011        PMID: 21228434     DOI: 10.1136/bmjqs.2010.048124

Source DB:  PubMed          Journal:  BMJ Qual Saf        ISSN: 2044-5415            Impact factor:   7.035


  4 in total

1.  Initial evaluation of thyroid dysfunction - Are simultaneous TSH and fT4 tests necessary?

Authors:  Claudio Schneider; Martin Feller; Douglas C Bauer; Tinh-Hai Collet; Bruno R da Costa; Reto Auer; Robin P Peeters; Suzanne J Brown; Alexandra P Bremner; Peter C O'Leary; Peter Feddema; Peter J Leedman; Drahomir Aujesky; John P Walsh; Nicolas Rodondi
Journal:  PLoS One       Date:  2018-04-30       Impact factor: 3.240

Review 2.  Effectiveness of interventions to reduce ordering of thyroid function tests: a systematic review.

Authors:  Zhivko Zhelev; Rebecca Abbott; Morwenna Rogers; Simon Fleming; Anthea Patterson; William Trevor Hamilton; Janet Heaton; Jo Thompson Coon; Bijay Vaidya; Christopher Hyde
Journal:  BMJ Open       Date:  2016-06-03       Impact factor: 2.692

Review 3.  The effectiveness of interventions to improve laboratory requesting patterns among primary care physicians: a systematic review.

Authors:  Sharon L Cadogan; John P Browne; Colin P Bradley; Mary R Cahill
Journal:  Implement Sci       Date:  2015-12-05       Impact factor: 7.327

Review 4.  Effectiveness of Practices to Support Appropriate Laboratory Test Utilization: A Laboratory Medicine Best Practices Systematic Review and Meta-Analysis.

Authors:  Matthew Rubinstein; Robert Hirsch; Kakali Bandyopadhyay; Bereneice Madison; Thomas Taylor; Anne Ranne; Millie Linville; Keri Donaldson; Felicitas Lacbawan; Nancy Cornish
Journal:  Am J Clin Pathol       Date:  2018-02-17       Impact factor: 2.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.